Terbinafine versus itraconazole: a long-term, randomized, double-blind, clinical trial in chronic pulmonary aspergillosis. A pilote study
Journal Title: Journal of Health and Social Sciences - Year 2016, Vol 1, Issue 1
Abstract
Background: The frequency of pulmonary aspergillosis has been increasing for decades. Standard oral treatment is associated with tolerability problems and interactions with commonly used medications. Present data suggest that terbinafine may be a useful alternative for chronic forms. Methods: A randomised, double-blind, multicentre trial compared terbinafine (500 mg b.i.d) with itraconazole (200 mg b.i.d.) with respect to successful outcomes for up to 6 months in 24 patients with chronic pulmonary aspergillosis. The primary end-point was a global clinical assessment using a 4-point rating scale, including (thorax) X-ray or Tc features. Secondary end-points were mycological response, duration of treatment and tolerability based on adverse events, haematology, biochemistry and urinalyses. Results: The patients were randomly allocated to terbinafine or itraconazole. No patients discontinued terbinafine, while 2 of 12 patients discontinued itraconazole because of protocol violation (n=1) or withdrawal of consent (n=1). The mean ± SD duration of the treatment was longer in the terbinafine group (139.8 ± 43.6 days vs 120.5 ± 41.8 days). The clinical success rate was also higher with terbinafine (91.7% vs 70.0%), as was the eradication rate (100% vs 75%). The proportion of patients who reported adverse events was higher with itraconazole (7 of 12 vs 3 of 12). Conclusions: Terbinafine (500 mg b.i.d. for up to 6 months) is an effective, well-tolerated antifungal agent for the treatment of chronic infectious forms of pulmonary aspergillosis, representing a valid alternative to treatment with itraconazole in these clinical forms, due to better clinical efficacy and safety and lower costs vs new azoles.
Authors and Affiliations
Gianfranco Schiraldi, Salvatore Lo Cicero, Claudio Rossetti, Delia Colombo, Michele Chiericozzi, Fabio Colombo, Maurizio Ferrarese, Elvana Kola, Luigi Allegra
Keywords
Related Articles
- EP ID EP216112
- DOI 10.19204/2016/trbn7
- Views 171
- Downloads 0
A case of asymptomatic ST segment changes in cyclist with two myocardial bridges
A 65-year-old male regularly involved in competitive cycling came to our sports medicine laboratory for the annual mandatory pre-participation screening. Cycling screening protocol includes a cardiological examination, b...
Germless Borders: A Review of “The Health of Newcomers: Immigration, Health Policy, and the Case for Global Solidarity”
People began to migrate approximately 70,000 years ago, and today, the migration of people across towns, providences, or countries has been propelled by improved transportation systems, civil wars, famine, and climate di...
Levofloxacin-induced visual hallucinations: A case report and review of the literature
A 52-year-old female, nonalcoholic, with no significant past medical history, was empirically treated with intravenous administration of levofloxacin (LVFX, 750 mg/day) for bronchopneumonia. On day 2, she reported seeing...
Efficacy of education strategies concerning organ shortage: state-of-the-art and proposals
Introduction: Aim of this study was to review the underlying reasons for organ shortage and the efficacy of current education programs, in order to propose messages to modify socio-psychological feelings to donation. Di...
The health of healthcare: Emergency department physician well-being
Introduction: Physician health and well-being is an important issue that ultimately aff ects job performance. We compared the self-reported incidence of known medical issues, physical and mental health symptoms, and heal...